DICER1 in pediatric and adult cancer predisposition populations: prevalence, phenotypes and mosaics.

Genet Med

Hereditary Cancer Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat-Girona, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Cancer Research Axis, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada. Electronic address:

Published: February 2025